Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Unfractionated Heparin in STEMI Primary PCI (STREAM Sub-study)
NCT00882635Phase 3Completed
- Start
- Oct 2008
- Primary completion
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of enoxaparin in ST elevation myocardial infarction (STEMI) (2 arms). Primary endpoint: Adequacy of anticoagulation with enoxaparin vs. unfractionated heparin. Started Oct 2008; status: completed.
02
Drugs
enoxaparin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00882635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882635.